Quantitative Thermoacoustic Tomography for in vivo breast tumor detection

2015 ◽  
pp. 2237-2240
Author(s):  
Lin Huang ◽  
Nengzhu Zhang ◽  
Yuan Zhao ◽  
Weizhi Qi ◽  
Huabei Jiang ◽  
...  
Keyword(s):  
Breast Tumor ◽  
Tumor Detection ◽  
Thermoacoustic Tomography

In vivo breast tumor detection using transient elastography

2003 ◽  
Vol 29 (10) ◽  
pp. 1387-1396 ◽  
Author(s):  
J. Bercoff ◽  
S. Chaffai ◽  
M. Tanter ◽  
L. Sandrin ◽  
S. Catheline ◽  
...  
Keyword(s):  
Breast Tumor ◽  
Transient Elastography ◽  
Tumor Detection

Block based compressive sensing method of microwave induced thermoacoustic tomography for breast tumor detection

2017 ◽  
Vol 122 (2) ◽  
pp. 024702 ◽  
Author(s):  
Shuangli Liu ◽  
Zhiqin Zhao ◽  
Xiaozhang Zhu ◽  
Yanxi Lu ◽  
Bingwen Wang ◽  
...  
Keyword(s):  
Compressive Sensing ◽  
Breast Tumor ◽  
Tumor Detection ◽  
Thermoacoustic Tomography ◽  
Block Based

Clinical Evaluation of Radio-Labelled Bleomycin for Tumor Detection

1978 ◽  
Vol 17 (06) ◽  
pp. 238-248
Author(s):  
H. Beekhuis ◽  
M.A.P.C. van de Poll ◽  
A. Versluis ◽  
H. Jurjens ◽  
M.G. Woldring ◽  
...  
Keyword(s):  
Clinical Evaluation ◽  
Acidic Solution ◽  
Tumor Detection ◽  
Neutral Solution ◽  
Normal Tissues ◽  
Patients With Cancer ◽  
Tumor Bearing

Investigations with bleomycin labelled with radionuclides other than 57Co in patients with cancer and in tumor-bearing animals are described. In patients 57Co-bleo appears to be a better tumor-seeking radiopharmaceutical than 111In-bleo, 99mTc-bleo or 197Hg-bleo. This can be explained by a higher stability in vivo and a better tumor-seeking property of 57Co-bleo and less disturbing activity in the cardiac pool and in bone and other normal tissues when assessing the scintigram.Results with 111In-bleo labelled in acidic solution are not essentially different from those with 111In-bleo labelled in neutral solution.Results of 197Hg-bleo are almost identical with those of 197HgCl2 regarding the tumor-seeking effect as well as the distribution in normal tissues and organs. Probably the complex of 197Hg to bleomycin is not stable in vivo. The superiority of 57Co-bleo over 99mTc-bleo, 197Hg-bleo and also over 67Cu-bleo is confirmed by experiments on tumor bearing animals.We may conclude that the indication for use of bleomycin as a tumor-seeking pharmaceutical labelled with 111In, 99mTc, 197Hg or 67Cu seems to be very limited.

Trends in Nanotechnology for in vivo Cancer Diagnosis: Products and Patents

2020 ◽  
Vol 26 (18) ◽  
pp. 2167-2181
Author(s):  
Tatielle do Nascimento ◽  
Melanie Tavares ◽  
Mariana S.S.B. Monteiro ◽  
Ralph Santos-Oliveira ◽  
Adriane R. Todeschini ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Quantum Dots ◽  
Magnetic Resonance ◽  
Metal Nanoparticles ◽  
Cancer Diagnosis ◽  
Imaging Techniques ◽  
Tumor Detection ◽  
Abnormal Growth ◽  
Pharmaceutical Nanotechnology

Background: Cancer is a set of diseases formed by abnormal growth of cells leading to the formation of the tumor. The diagnosis can be made through symptoms’ evaluation or imaging tests, however, the techniques are limited and the tumor detection may be late. Thus, pharmaceutical nanotechnology has emerged to optimize the cancer diagnosis through nanostructured contrast agent’s development. Objective: This review aims to identify commercialized nanomedicines and patents for cancer diagnosis. Methods: The databases used for scientific articles research were Pubmed, Science Direct, Scielo and Lilacs. Research on companies’ websites and articles for the recognition of commercial nanomedicines was performed. The Derwent tool was applied for patent research. Results: This article aimed to research on nanosystems based on nanoparticles, dendrimers, liposomes, composites and quantum dots, associated to imaging techniques. Commercialized products based on metal and composite nanoparticles, associated with magnetic resonance and computed tomography, have been observed. The research conducted through Derwent tool displayed a small number of patents using nanotechnology for cancer diagnosis. Among these patents, the most significant number was related to the use of systems based on metal nanoparticles, composites and quantum dots. Conclusion: Although few systems are found in the market and patented, nanotechnology appears as a promising field for the development of new nanosystems in order to optimize and accelerate the cancer diagnosis.

Numerical Simulation of Tunable Terahertz Graphene-Based Sensor for Breast Tumor Detection

2021 ◽  
Vol 21 (8) ◽  
pp. 9844-9851
Author(s):  
Aymen Hlali ◽  
Afef Oueslati ◽  
Hassen Zairi
Keyword(s):  
Numerical Simulation ◽  
Breast Tumor ◽  
Tumor Detection

3-D-Microwave Breast Tumor Detection: Study of System Performance

2008 ◽  
Vol 55 (12) ◽  
pp. 2772-2777 ◽  
Author(s):  
M.E. de Rodriguez ◽  
M. Vera-Isasa ◽  
V.S. del Rio
Keyword(s):  
Breast Tumor ◽  
System Performance ◽  
Tumor Detection
Sign in / Sign up

Export Citation Format

Share Document